UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessment of causality of individual adverse events following immunization (AEFI): A WHO tool for global use

Vaccine, 2013-10, Vol.31 (44), p.5041-5046

2013

Volltextzugriff (PDF)

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level

Bulletin of the World Health Organization, 2014-09, Vol.92 (9), p.695-696

2014

Volltextzugriff (PDF)

Global landscape analysis of no-fault compensation programmes for vaccine injuries: A review and survey of implementing countries

PloS one, 2020-05, Vol.15 (5), p.e0233334-e0233334

2020

Volltextzugriff (PDF)

Immunization stress-related response – Redefining immunization anxiety-related reaction as an adverse event following immunization

Vaccine, 2020-03, Vol.38 (14), p.3015-3020

2020

Volltextzugriff (PDF)

Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015

Vaccine, 2018-03, Vol.36 (12), p.1577-1582

2018

Volltextzugriff (PDF)

The use of web analytics combined with other data streams for tailoring online vaccine safety information at global level: The Vaccine Safety Net’s web analytics project

Vaccine, 2020-09, Vol.38 (41), p.6418-6426

2020

Volltextzugriff (PDF)

Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women

Vaccine, 2016-12, Vol.34 (49), p.5998-6006

2016

Volltextzugriff (PDF)

Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment

Vaccine, 2018-10, Vol.36 (45), p.6736-6743

2018

Volltextzugriff (PDF)

The Safety of PsA-TT in Pregnancy: An Assessment Performed Within the Navrongo Health and Demographic Surveillance Site in Ghana

Clinical infectious diseases, 2015-11, Vol.61 (suppl_5), p.S489-S492

2015

Volltextzugriff (PDF)

Introduction of Hib vaccine into national immunization programmes: A descriptive analysis of global trends

Vaccine, 2007-10, Vol.25 (41), p.7075-7080

2007

Volltextzugriff (PDF)

Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years

Vaccine, 2016-06, Vol.34 (29), p.3342-3349

2016

Volltextzugriff (PDF)

Evolving pharmacovigilance requirements with novel vaccines and vaccine components

BMJ global health, 2021-05, Vol.6 (Suppl 2), p.e003403

2021

Volltextzugriff (PDF)

Research priorities regarding rotavirus vaccine and intussusception: A meeting summary

Vaccine, 2012-04, Vol.30, p.A179-A184

2012

Volltextzugriff (PDF)

Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010

Vaccine, 2012-05, Vol.30, p.B46-B51

2012

Volltextzugriff (PDF)

Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience

Vaccine, 2009-01, Vol.27 (3), p.410-415

2009

Volltextzugriff (PDF)

Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali

Clinical infectious diseases, 2015-11, Vol.61 (suppl_5), p.S493-S500

2015

Volltextzugriff (PDF)

Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013

Clinical infectious diseases, 2015-11, Vol.61 (suppl_5), p.S459-S466

2015

Volltextzugriff (PDF)

Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010

Vaccine, 2012-07, Vol.30 (35), p.5229-5234

2012

Volltextzugriff (PDF)

Sustaining GAVI-supported vaccine introductions in resource-poor countries

Vaccine, 2011-04, Vol.29 (17), p.3149-3154

2011

Volltextzugriff (PDF)

Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries

Vaccine, 2019-07, Vol.37 (31), p.4370-4375

2019

Volltextzugriff (PDF)

A Prospective Cohort Study on the Safety of Infant Pentavalent (DTwP-HBV-Hib) and Oral Polio Vaccines in Two South Indian Districts

The Pediatric infectious disease journal, 2020-05, Vol.39 (5), p.389-396

2020

Volltextzugriff (PDF)

The science of vaccine safety: Summary of meeting at Wellcome Trust

Vaccine, 2020-02, Vol.38 (8), p.1869-1880

2020

Volltextzugriff (PDF)

Predictors of Virologically Confirmed Poliomyelitis in India, 1998–2000

Clinical infectious diseases, 2002-12, Vol.35 (11), p.1321-1327

2002

Volltextzugriff (PDF)

Enhancing Vaccine Safety Capacity Globally: A Lifecycle Perspective

American journal of preventive medicine, 2015-12, Vol.49 (6 Suppl 4), p.S364

2015

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(72)

Sprache

Englisch
(71)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessment of causality of individual adverse events following immunization (AEFI): A WHO tool for global use

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level

Global landscape analysis of no-fault compensation programmes for vaccine injuries: A review and survey of implementing countries

Immunization stress-related response – Redefining immunization anxiety-related reaction as an adverse event following immunization

Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015

The use of web analytics combined with other data streams for tailoring online vaccine safety information at global level: The Vaccine Safety Net’s web analytics project

Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women

Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment

The Safety of PsA-TT in Pregnancy: An Assessment Performed Within the Navrongo Health and Demographic Surveillance Site in Ghana

Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience

Introduction of Hib vaccine into national immunization programmes: A descriptive analysis of global trends

Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years

Evolving pharmacovigilance requirements with novel vaccines and vaccine components

Research priorities regarding rotavirus vaccine and intussusception: A meeting summary

Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010

Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience

Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali

Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013

Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010

Sustaining GAVI-supported vaccine introductions in resource-poor countries

Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries

A Prospective Cohort Study on the Safety of Infant Pentavalent (DTwP-HBV-Hib) and Oral Polio Vaccines in Two South Indian Districts

The science of vaccine safety: Summary of meeting at Wellcome Trust

Predictors of Virologically Confirmed Poliomyelitis in India, 1998–2000

Enhancing Vaccine Safety Capacity Globally: A Lifecycle Perspective

Suchergebnisse filtern